Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 31,482

Document Document Title
WO/2017/052099A1
Disclosed are a compound represented by chemical formula 1, an organic electronic device including a first electrode, a second electrode, and an organic material layer between a first electrode and a second electrode, and an electronic d...  
WO/2017/050609A1
A compound of formula (I) for use in electrolyte compositions for electrochemical cells.  
WO/2017/049409A1
Disclosed are compounds of general formula (I) that promote readthrough of a premature termination codon (PTC) of an RNA molecule in a translation system, and their use, alone or in combination with other compounds, such as aminoglycosid...  
WO/2017/051354A1
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the p...  
WO/2017/045271A1
The present invention relates to the field of pharmaceutical chemistry, and specifically to a class of benzofuran derivatives (I). Pharmacodynamic tests prove that these compounds can be used for anti-tumor purposes and have a medical th...  
WO/2017/049211A1
Provided herein are methods of producing halomethylfuroic and acyloxymethylfuroic acid and ester compounds from furfural starting compounds. For example, 5-chloromethyl-2-furoic acid may be produced from 5-chloromethylfurfural, in the pr...  
WO/2017/049239A1
Provided herein are methods of producing polymers from furan and optionally diol compounds, using an organocatalyst. The furan compounds may include, for example, 2,5-furandicarboxylic acid or 2,5-tetrahydrofurandicarboxylic acid. Provid...  
WO/2017/048025A1
The present invention provides a novel compound capable of improving the luminous efficiency, stability, and life of an element, an organic electronic element using same, and an electronic device comprising same.  
WO/2017/046355A1
The invention relates to a method for the stereoselective preparation of compounds of formula (IV).  
WO/2017/048864A1
The present invention provides methods of making furfural fatty acids from (chloromethyl)furfural. The present invention also provides furfural fatty acids and nutritional supplements that include furfural fatty acids.  
WO/2017/047992A1
The present specification relates to a heterocyclic compound and an organic light emitting device comprising the same.  
WO/2017/042289A1
The present invention provides a process for the production of 1,4-BDO and THF from furan, said process comprising : (i) contacting furan with hydrogen and water in a reactor in the presence of a catalytic composition, wherein the furan ...  
WO/2017/043757A1
The present invention relates to an organic compound represented by chemical formula 1, an organic optoelectronic diode, and a display device.  
WO/2017/043835A1
The present invention provides: a compound capable of improving the high light emitting efficiency, the low driving voltage of a diode, and the lifespan of the diode; an organic electronic diode using the same; and a device therefor.  
WO/2017/041228A1
The present invention relates to the field of pharmaceutical synthesis, in particular to a method for preparing a hexahydrofurofuranol derivative, an intermediate thereof and a preparation method thereof. The preparation method uses a co...  
WO/2017/041139A1
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.  
WO/2017/044957A1
The present invention relates to the synthesis of intermediate compounds which can be used in the synthesis of mint lactone and related compounds, including 3,6-dimethylhexahydrobenzofuran-2-ones, isomers, and other derivatives.  
WO/2017/043652A1
Provided are: an organic electroluminescent element containing, between a negative electrode and a positive electrode, a light-emitting layer that contains a compound represented by formula (1) and a compound represented by formula (11);...  
WO/2017/036574A1
The present application relates to a compound of a formula (I) or (II) where Ar1 is the same or different at each instance and is an aryl or heteroaryl group which has 6 to 18 aromatic ring atoms and may be substituted by one or more R1 ...  
WO/2017/035982A1
The present invention relates to the field of medicinal chemistry, and in particular, to diazonaphthoquinone compounds having antineoplastic activity and a preparation method for the compounds. The compounds can be activated by reduced c...  
WO/2017/040191A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2017/037616A1
The invention relates to arylalkylamine compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated...  
WO/2017/036573A1
The present application relates to phenanthrene compounds of a particular formula (I), their use in electronic devices, electronic devices comprising such phenanthrene compounds, as well as processes for the synthesis of such phenanthren...  
WO/2017/036392A1
A derivative of inula lineariifolia lactone A, and in particular, a dimethylamine 4-O-acetyl inula lineariifolia lactone A or a salt thereof, preparation for same, and an application of same in preparation of medicine for treating multip...  
WO/2017/040194A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2017/034985A1
The invention relates generally to the preparation of hydroxymethyl furfural derivatives such as 5-carboxymethyl furfural derivatives, ethers such as 5-alkoxymethyl furfural derviatives, 5-hydroxymethyl furfural, levulinic acid, levulini...  
WO/2017/027967A1
The present application relates to a-substituted amino acid compounds of the Formula (I), compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions characterized by or ass...  
WO/2017/030307A1
The present invention provides a compound represented by chemical formula 1. In addition, the present invention provides an organic electronic element comprising a first electrode, a second electrode, and an organic material layer betwee...  
WO/2017/030684A1
A catalytic process for the dehydrative cyclization of pentitols to synthesize anhydropentitols is described. Water-tolerant Lewis acids (in particular, metal triflates) are employed as catalysts to improve conversion and anhydropentitol...  
WO/2017/030424A1
A light emitting diode according to the present invention comprises: a first electrode; an organic layer provided on the first electrode; a light emitting layer provided on the organic layer; an electron transport layer provided on the l...  
WO/2017/030685A1
A process for preparing anhydropentitol mono- and diethers from C5 sugar alcohols is described. The process involves performing in a single reaction vessel consolidated reactions that a) cyclize dehydratively a linear C5 sugar alcohol an...  
WO/2017/030019A1
A tetracarboxylic dianhydride which is a compound represented by general formula (1) (wherein multiple R1's independently represent a hydrogen atom or the like; and R2 and R3 independently represent a hydrogen atom or the like].  
WO/2017/027706A1
A method is described for making single isomers of synthetic beraprost diol, a key intermediate for making 314-d isomer of beraprost. The method requires fewer steps than the known methods for making these compounds and can be used to sc...  
WO/2017/027845A1
Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), ...  
WO/2017/027841A1
Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), ...  
WO/2017/024229A8
A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium...  
WO/2017/024229A1
A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium...  
WO/2017/022730A1
A compound indicated by formula (1). In formula (1), R1-R5, a-e, L1-L3, Ar, and X are as defined in the Description.)  
WO/2017/022727A1
A compound indicated by formula (1) can provide an organic electroluminescence element having improved performance. (In formula (1), R1-R3, a-c, L1-L3, Ar1, and Ar2 are as defined in the Description.)  
WO/2017/019441A1
A process for producing furan dicarboxylic acid or an ester thereof from a feedstock comprising hydroxymethyl furfural (HMF) and humins is disclosed. Humins are a byproduct from reactions forming HMF from sugars and are typically removed...  
WO/2017/019445A1
A process for efficiently esterifying furan dicarboxylic acid, especially 2,5-furan dicarboxylic acid in the presence of an alcohol and, optionally, a catalyst is disclosed. The process provides high yields of the diesters of furan dicar...  
WO/2017/019447A1
Disclosed are processes for producing the dialkyl ester of 2,5-furan dicarboxylic acid by contacting a feed containing 2,5-furan dicarboxylic acid and a high boiling solvent with an alcohol in the presence of a solid acid catalyst using ...  
WO/2017/019636A1
Compounds, methods, compositions and kits for treating a patient with pulmonary sarcoidosis are provided. The compositions are formulated for delivery to a patient in need of treatment via inhalation. In one embodiment, the method of tre...  
WO/2017/016925A1
The invention relates to a new method for transforming feedstock comprising at least one sugar into 5-(hydroxymethyl)furfural, in which method the feedstock is brought into contact with one or more organic catalysts in the presence of at...  
WO/2017/016923A1
The invention relates to a new method for transforming feedstock comprising at least one sugar into 5-(hydroxymethyl)furfural, in which method the feedstock is brought into contact with one or more organic catalysts in the presence of at...  
WO/2017/016924A1
The invention relates to a new method for transforming feedstock comprising at least one sugar into 5-(hydroxymethyl)furfural, in which method the feedstock is brought into contact with one or more organic catalysts in the presence of at...  
WO/2017/018617A1
Provided are: a compound including cations and anions, wherein the cations are represented by a specific formula; a photosensitive resin composition containing the compound; and a color filter manufactured using the photosensitive resin ...  
WO/2017/019444A1
Processes for preparing a dialkyl ester of 2,5-furan dicarboxylic acid are disclosed. The processes comprise contacting 2,5-furan dicarboxylic acid with excess alcohol and, optionally, a catalyst at a pressure in the range of between 1 b...  
WO/2017/019431A1
Disclosed herein are processes for producing 2,5-furandicarboxylic acid dialkyl ester. In one embodiment, the process comprises a) contacting 2,5-furan dicarboxylic acid, excess alcohol, and optionally, a catalyst in a reactor at a tempe...  
WO/2017/019589A1
The present disclosure features compounds such as those having the Formulae (I) and (II), which can increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells. The p...  

Matches 151 - 200 out of 31,482